Rilotumumab
Rilotumumab (AMG 102) is a monoclonal antibody targeting hepatocyte growth factor that inhibits HGF/ MET-driven signaling. Rilotumumab has antitumor effects and can be used to study castration-resistant prostate cancer (CRPC) and gastric cancer.
Product Specifications
CAS Number
872514-65-3
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
C-Met/HGFR
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS074427-01 48 Well
Camel Signal Transducer and Activator of Transcription 1 ELISA Kit
Ask
View Details 
MBS074427-02 96 Well
Camel Signal Transducer and Activator of Transcription 1 ELISA Kit
Ask
View Details